Jefferies Group LLC Arvinas, Inc. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$60.45 - $84.26 $670,995 - $935,286
-11,100 Closed
0 $0
Q1 2021

Sep 21, 2023
BUY
$58.19 - $91.37 $645,909 - $1.01 Million
11,100 New
11,100 $733,000
Q1 2021

May 14, 2021
BUY
$58.19 - $91.37 $645,909 - $1.01 Million
11,100 New
11,100 $734,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $1.02B
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email